XI, L., DJ, G., J, v. d. A., J, C., H, A., GJ, B., & A, D. (2024). Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms. Journal of clinical pharmacology, 64(11), 1443. https://doi.org/10.1002/jcph.2496
Chicago Style (17th ed.) CitationXI, Liu, Green DJ, van den Anker J, Calderon J, Ahmadzia H, Burckart GJ, and Dallmann A. "Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms." Journal of Clinical Pharmacology 64, no. 11 (2024): 1443. https://doi.org/10.1002/jcph.2496.
MLA (9th ed.) CitationXI, Liu, et al. "Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms." Journal of Clinical Pharmacology, vol. 64, no. 11, 2024, p. 1443, https://doi.org/10.1002/jcph.2496.
Warning: These citations may not always be 100% accurate.